Type 2 immunity, long characterized by its role in allergy and antiparasitic defense, also functions as a homeostatic circuit that restrains inflammation and maintains hematopoietic, macrophage and metabolic balance. The authors propose that progressive erosion of this axis with age contributes to chronic low-grade inflammation, positioning its restoration as a candidate gerotherapeutic strategy.
Key Points
- Type 2 immunity restrains inflammation beyond allergy and parasite defense
- Age-related decline of this axis may drive inflammaging
- Restoring immune homeostasis proposed as gerotherapeutic target
Longevity Analysis
Most anti-inflammatory strategies in aging target the drivers of inflammation rather than the endogenous circuits that resolve it. Reframing inflammaging as a failure of counter-regulation shifts attention toward the body's own braking mechanisms — the signals that tell immune cells, bone marrow and tissue macrophages when to stand down. Interpreting chronic inflammatory load correctly, rather than simply suppressing it, determines whether an intervention restores defensive balance or further blunts it.
Original published by Nature Aging, by Jingfei Yao.